Aciclovir 200mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

aciclovir 200mg tablets

wockhardt uk ltd - aciclovir - oral tablet - 200mg

Ibuprofen 200mg caplets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ibuprofen 200mg caplets

lloyds pharmacy ltd - ibuprofen - oral tablet - 200mg

Metronidazole 200mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

metronidazole 200mg tablets

sandoz ltd - metronidazole - oral tablet - 200mg

Ibuprofen 200mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ibuprofen 200mg tablets

bristol laboratories ltd - ibuprofen - oral tablet - 200mg

Metronidazole 200mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

metronidazole 200mg tablets

milpharm ltd - metronidazole - oral tablet - 200mg

Aciclovir 200mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

aciclovir 200mg tablets

mawdsley-brooks & company ltd - aciclovir - oral tablet - 200mg

Zurampic 200 mg Film coated tablet New Zealand - English - Medsafe (Medicines Safety Authority)

zurampic 200 mg film coated tablet

astrazeneca limited - lesinurad 200 mg - film coated tablet - 200 mg

DIFLUCAN fluconazole 200 mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

diflucan fluconazole 200 mg capsule blister pack

pfizer australia pty ltd - fluconazole, quantity: 200 mg - capsule, hard - excipient ingredients: colloidal anhydrous silica; indigo carmine; lactose monohydrate; erythrosine; sodium lauryl sulfate; titanium dioxide; maize starch; gelatin; magnesium stearate; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; ethanol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; industrial methylated spirit; dimeticone 1510; lecithin - indications as at 21 may 2004 : diflucan, given orally, is indicated for: 1. treatment of cryptococcal meningitis in patients who are unable to tolerate amphotericin b. note : data suggest that the clinical efficacy of diflucan is lower than that of amphotericin b in the treatment of the acute phase of cryptococcal meningitis. 2. maintenance therapy to prevent relapse of cryptococcal meningitis in patients with aids. 3. treatment of oropharyngeal and oesophageal candidiasis in aids and other immunosuppressed patients. 4. secondary prophylaxis of oropharyngeal candidiasis in patients with hiv infection. 5. serious and life-threatening candida infections in patients who are unable to tolerate amphotericin b. note : it remains to be shown that diflucan is as effective as amphotericin b in the treatment of serious and life-threatening candida infections. until such data are available, amphotericin b remains the drug of choice. 6. vaginal candidiasis when topical therapy has failed. 7. treatment of extens

Amisulprid Sandoz 200 mg tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

amisulprid sandoz 200 mg tabl.

sandoz sa-nv - amisulpride 200 mg - tablet - 200 mg - amisulpride 200 mg - amisulpride

Amoclane 2000 mg - 200 mg inf. sol. (pwdr.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

amoclane 2000 mg - 200 mg inf. sol. (pwdr.) i.v. vial

eg sa-nv - potassium clavulanate - eq. clavulanic acid 200 mg; amoxicillin sodium - eq. amoxicillin 2000 mg - powder for solution for infusion - 2000 mg - 200 mg - clavulanic acid 200 mg; amoxicillin sodium - amoxicillin and enzyme inhibitor